Digital Pathology Market: Global Industry Analysis and Forecast (2021-2027) by End User, Application

Digital Pathology Market was estimated to be USD 704.43 Mn. in 2020, and is expected to reach USD 1355.67 Mn. by 2027, registering a CAGR of 10.43%, during the period of 2021-2027.

Digital Pathology Market Overview:

Digital pathology involves converting a specimen slide used in performing pathology operations into a digital image, which then can be viewed using a computer or dedicated image analysis equipment. For performing digital pathology operations, three main components are used: hardware, software, and storage. Hardware involves scanner equipment, which is used for scanning a specimen slide for converting it into a digital image with high magnification ranging from 2x to 100x, which is referred to as a Whole Slide Image (WSI). The software component is used for viewing and analyzing this digital image. It involves image analysis algorithms equipped with AI. AI uses machine learning and deep learning abilities to provide better analysis of any scanned image. The storage component is used for storing whole slide images. Digital Pathology Market To know about the Research Methodology :- Request Free Sample Report

Digital Pathology Market Dynamics:

Drivers:

Healthcare is rapidly evolving through the adoption of various approaches such as patient-centric and value-based models, digital transformation, data-driven personalization of care and treatment, coordinated care, and others. Such factors are shaping the healthcare industry to have maximum productivity by providing quality care at an affordable cost. These factors are expected to shape healthcare during the forecast period to address the growing population of the world. Digital pathology can improve the application of digital health as it includes performing pathological operations using digital tools. It uses two components – automated digital pathology scanners and digital pathology software applications. A scanner is used for creating a high-magnification image of the specimen slide, which is then examined, and based on this, a diagnosis is provided. The high magnification image created using the automated scanners is generally stored on the system itself. The size of one typical whole slide image (WSI) ranges between 50 MB and 6 GB. For storing such an enormous amount of data, many digital pathology labs and service providers are now using cloud-based solutions, which also makes sharing these files easier. Many digital pathology vendors use AI software and algorithms based on the type of specimen being examined. Such algorithms perform an analysis of a huge set of data in no time. During COVID-19, digitalization was implemented in many developed and developing countries. Healthcare facilities across the countries adopted telehealth measures to perform non-COVID-19 practices, such as general physicians, orthopedics, etc. It resulted in increased adoption of tele pathology and digital pathology services. Healthcare facilities acquired digital pathology solutions to effectively manage their workflows during the pandemic.

Restraints:

Digital pathology comes with very precise requirements for its use in primary diagnosis and remote pathology. The IntelliSite slide scanner by Philips, which is considered a standard in the digital pathology industry, has the requirements of high bandwidth connectivity for enabling remote pathology. Remote pathology is one of the major advantages of digital pathology. This is because it enables taking a second opinion on any slide from pathologists across the world in real-time. The WSI is shared with other pathologists using cloud storage services or other solutions for data sharing, which requires high internet connectivity for sending as well as receiving the image file without losing its quality. This ensures proper visualization of the WSI to produce quality results. In low-resource countries, there is a lack of infrastructure that can enable real-time sharing or receiving of large size data files. It can produce low-quality images and a high waiting time, which makes digital pathology solutions harder for large networks. In such situations, local networks can be used, which can eliminate this challenge. But using a local network limits the use of digital pathology to only that region. Another limiting factor for the implementation of digital pathology in low-resource countries is the cost of the equipment. IntelliSite by Philips costs around $250,000 to $300,000, which is not affordable by small laboratories in developed countries or developing countries. This is also applicable for academic institutes in such countries, where they lack the financial resources to procure such high-end equipment. Low-resource countries usually have a high disease burden due to lack of proper healthcare. These countries contribute significantly to the disease burden but have very limited pathology and laboratory medicine services. Such countries also lack in human resources or the workforce required for managing pathological needs. It is also coupled with the lack of standardization and quality control guidelines. Many sub-Saharan countries have a pathologist to population ratio over 1:1,000,000. Such stringent situations are restricting the growth of digital pathology solutions in such countries.

COVID-19 Impact on Digital Pathology Market:

During the COVID-19 pandemic, the burden on healthcare and pathology labs increased exponentially. Pathology labs witnessed an almost 250% increase in the volume of specimen samples for testing. This increased volume was a much bigger problem as pathologists were forced to work from home. This was also affected by changes in regulatory guidelines on the grounds of COVID-19. The countries affected most by COVID-19 have shown the maximum acceptance for digital pathology solutions. Many countries had shown acceptance for these solutions even when they were mildly or moderately affected by the infection. During COVID-19, the FDA also relaxed its restrictions over the use of digital pathology solutions and provided many guidelines for its use in remote pathology. This approach helped in increasing the acceptance of digital pathology among pathologists across the US. It was also seen in the European market, as it increased the use of digital pathology. Many hospital chains across Europe opted for the digitalization of their workflow. Because of this, the demand for digital pathology solutions to monitor pathological workflows increased. It was a result of the increased demand for Sectra’s digital pathology solutions. During COVID-19, and in the current phase, Sectra has received many orders from healthcare facilities across Europe and the US.

Digital Pathology Market Segment Analysis:

The digital pathology market has been segmented into three distinct segments by application as academic research & teaching, disease diagnosis, and drug discovery & development. In 2020, the segment of academic research & teaching acquired a 48.39% market share of the digital pathology market. During the forecast period, it is expected to retain its leading position. Following the academic research & teaching segment, the disease diagnosis segment and drug discovery & development segment acquired a market share of 27.25% and 24.36% in 2020, respectively. Digital Pathology Market 1 Digital pathology allows converting the specimen slides used in pathology into a digital image with magnification up to 100 times. It is widely used for performing research as it is easy to document and share these images than the actual specimen slide. Because of the same reason, it is also widely used for teaching. There are several research areas in which digital pathology is currently being applied, such as biotechnology, pharmacy, medical science, and clinical research. In the European region, digital pathology solutions, including WSI scanners, viewers, and analyzing software, are considered as medical devices used for in-vitro diagnosis. However, it is necessary to obtain a CE-marking for any digital pathology product, which is to be used for primary diagnosis. Many vendors such as Philips, Roche, and Leica Biosystems are providing digital pathology solutions for primary diagnosis in this region. In the US, digital pathology solutions are majorly restricted to research and educational purposes. The digital pathology market is segmented into three segments based on the component type – hardware, software, and storage. The hardware segment in 2020 held a leading position in the market with a market share of 61.60%. It was followed by the software and storage segment, each acquiring a market share of 24.90% and 13.50%, respectively. There are three distinct components that together form the digital pathology system. Many key vendors are focusing on manufacturing hardware and software, which are the more important and functional part of the digital pathology system. Storage solutions are provided by other prominent vendors that offer cloud storage services or local storage services. The hardware segment covers WSI scanners, which are used for making a digital image or a whole slide image (WSI) of a specimen slide. The software segment deals with image analysis software and analyzing algorithms, which are used for viewing, analyzing, and managing WSIs. The storage segment includes various storage solutions such as hard drives or removable drives, cloud storage, and hybrid cloud structures. The pathology market by end-user has been segmented as academic & research institutes, diagnostic & pathology labs, clinical research organizations, and pharmaceutical & biotechnology companies. Academic & research institutes were the leading segment of the market in 2020, with a market share of 48.33%. It was followed by diagnostic & pathology labs, clinical research organizations, and pharmaceutical & biotechnology companies with a market share of 27.25%, 14.80%, and 9.63%, respectively. The end-user segmentation is an important segment to understand the market for digital pathology and its growth in the future. The digital pathology market has four distinct end-users – academic & research institutes, diagnostic & pathology labs, clinical research organizations, and pharmaceutical & biotechnology companies. Primarily, the use of digital pathology was mostly seen in academic & research institutes as it is better to study the specimen than conventional light microscopy. But with technological advances in digital pathology and increasing acceptance of digital pathology by pathologists, it is seeing increased use by other end-users. The important growth enabler for this is the use of digital pathology in clinical trials and clinical research. FDA suggested using remote digital pathology devices during the pandemic. This is expected to increase the acceptance of digital pathology among pathologists across the US for diagnosis, which has been low over the past years.

Digital Pathology Market Regional Insights:

The digital pathology market is an emerging market that is expected to grow at a rapid pace during the forecast period with a CAGR of 10.43% because of the digitalization of healthcare and increasing demand for pathology due to the disease burden on many developed and developing countries. The market is segmented as per regions as North America, Europe, APAC, Latin America, and the Middle East & Africa. Based on the market share and revenue values, North America emerged as a market leader. It accounted for a 36.28% market share of the digital pathology market, followed by Europe, APAC, Latin America, and the Middle East & Africa, with a market share of 31.76%, 19.77%, 7.27%, and 4.92%, respectively. Digital Pathology Market 2 The digital pathology market is rapidly growing and is expected to soon be ly accepted as a way of performing pathological operations. The major drivers for this transition are a shortage of pathologists. The scarce availability of pathologists has many implications on the pathology sector of any country. It creates a burden of pending cases in pathology labs as there is no adequate staff to address the situation. This creates a delay in the diagnosis, which further delays the treatment procedure. Such practice is not suitable in critical illness. Currently, WSI scanners are considered medical devices in many countries and are well regulated for their use as in-vitro diagnostic medical devices. Even after this, WSI scanners are not widely accepted in the US market because of the associated doubts. Many pathologists across the country are in doubt regarding the usability of digital pathology solutions, especially WSI scanners. Because of this, even to this date, there are only two FDA-approved WSI scanners in the country. In the European region, for approval of WSI scanners, vendors must produce validation by pathologists regarding the accuracy of the device. Based on this, the device is awarded the CE-marking for marketing the device in the European Union. In other regions such as APAC, regulations are provided as per the country guidelines. Most countries in the region follow FDA guidelines, which is why the market shares of Philips and Leica Biosystems are higher in the region than other vendors. Hamamatsu Photonics, being one of the leading native players, also has a significant market share in the region. The objective of the report is to present a comprehensive analysis of the Digital Pathology market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Digital Pathology market dynamics, structure by analyzing the market segments and project the Digital Pathology market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Digital Pathology market make the report investor’s guide.

Digital Pathology Market Scope: Inquire before buying

Digital Pathology Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US$ 704.43 Mn.
Forecast Period 2021 to 2027 CAGR: 10.43% Market Size in 2027: US$ 1355.67 Mn.
Segments Covered: by Application • Academic Research & Teaching • Disease Diagnosis • Drug Discovery & Development
by Component • Hardware • Software • Storage
by End User • Diagnostic & Pathology Labs • Pharmaceutical & Biotechnology Companies • Clinical Research Organizations • Academic & Research Institutes

Digital Pathology Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Digital Pathology Market Key Players

• Philips • Roche • Leica Biosystems Nussloch • Hamamatsu Photonics • Sectra Ab • 3dhistech • Hologic • Aiforia • Akoya Biosciences • Deep Lens • Deciphex • Huron • Ibex Medical Analytics • Instapath • Inspirata • Microsoft • Nvidia • Optrascan • Paige Ai • Pathologywatch • Proscia • Sonrai Analytics • Visiopharm • Visikol
1. Digital Pathology Market: Research Methodology 2. Digital Pathology Market: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Digital Pathology Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Digital Pathology Market: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12. COVID-19 Impact 4. Digital Pathology Market Segmentation 4.1. Digital Pathology Market, by Application (2020-2027) • Academic Research & Teaching • Disease Diagnosis • Drug Discovery & Development 4.2. Digital Pathology Market, by Component (2020-2027) • Hardware • Software • Storage 4.3. Digital Pathology Market, by End User (2020-2027) • Diagnostic & Pathology Labs • Pharmaceutical & Biotechnology Companies • Clinical Research Organizations • Academic & Research Institutes 5. North America Digital Pathology Market (2020-2027) 5.1. North America Digital Pathology Market, by Application (2020-2027) • Academic Research & Teaching • Disease Diagnosis • Drug Discovery & Development 5.2. North America Digital Pathology Market, by Component (2020-2027) • Hardware • Software • Storage 5.3. North America Digital Pathology Market, by End User (2020-2027) • Diagnostic & Pathology Labs • Pharmaceutical & Biotechnology Companies • Clinical Research Organizations • Academic & Research Institutes 5.4. North America Digital Pathology Market, by Country (2020-2027) • United States • Canada • Mexico 6. European Digital Pathology Market (2020-2027) 6.1. European Digital Pathology Market, by Application (2020-2027) 6.2. European Digital Pathology Market, by Component (2020-2027) 6.3. European Digital Pathology Market, by End User (2020-2027) 6.4. European Digital Pathology Market, by Country (2020-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest of Europe 7. Asia Pacific Digital Pathology Market (2020-2027) 7.1. Asia Pacific Digital Pathology Market, by Application (2020-2027) 7.2. Asia Pacific Digital Pathology Market, by Component (2020-2027) 7.3. Asia Pacific Digital Pathology Market, by End User (2020-2027) 7.4. Asia Pacific Digital Pathology Market, by Country (2020-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest of APAC 8. Middle East and Africa Digital Pathology Market (2020-2027) 8.1. Middle East and Africa Digital Pathology Market, by Application (2020-2027) 8.2. Middle East and Africa Digital Pathology Market, by Component (2020-2027) 8.3. Middle East and Africa Digital Pathology Market, by End User (2020-2027) 8.4. Middle East and Africa Digital Pathology Market, by Country (2020-2027) • South Africa • GCC • Egypt • Nigeria • Rest of ME&A 9. Latin America Digital Pathology Market (2020-2027) 9.1. Latin America Digital Pathology Market, by Application (2020-2027) 9.2. Latin America Digital Pathology Market, by Component (2020-2027) 9.3. Latin America Digital Pathology Market, by End User (2020-2027) 9.4. Latin America Digital Pathology Market, by Country (2020-2027) • Brazil • Argentina • Rest of Latin America 10. Company Profile: Key players 10.1. Phillips 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Roche 10.3. Leica Biosystems Nussloch 10.4. Hamamatsu Photonics 10.5. Sectra Ab 10.6. 3dhistech 10.7. Hologic 10.8. Aiforia 10.9. Akoya Biosciences 10.10. Deep Lens 10.12. Deciphex 10.13. Huron 10.14. Ibex Medical Analytics 10.15. Instapath 10.16. Inspirata 10.17. Microsoft 10.18. Nvidia 10.19. Optrascan 10.20. Paige Ai 10.21. Pathologywatch 10.22. Proscia 10.23. Sonrai Analytics 10.24. Visiopharm 10.25. Visikol

About This Report

Report ID 3486
Category Healthcare
Published Date Oct 2019
Updated Date Dec 2021
Contact Us